/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All amounts expressed in Canadian dollars unless otherwise noted TORONTO and RIONEGRO, Colombia, Oct. 06, 2025 (GLOBE NEWSWIRE) -- PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced the closing of the sale of its ...

公司特别会议安排 - 因加拿大邮政罢工，公司特别会议材料可能无法在2025年10月27日会议前送达所有股东[1] - 股东可通过公司SEDAR+、EDGAR档案或官网获取会议材料[2] - 公司建议股东在线投票，不要邮寄投票代理表，以确保投票指令及时接收[3] 股东投票与异议权安排 - 公司接受代理投票的截止时间至少为2025年10月24日中部时间上午9:30[3] - 受益股东应在代理截止时间前至少24小时提交投票[3][5] - 登记股东可通过联系Odyssey Trust Company获取控制编号或投票协助[4] - 登记股东有权对会议提案提出异议，书面异议通知须在2025年10月23日太平洋夏令时间上午9:30前送达指定地址[6] 公司业务概况 - Verano是美国大麻行业领先的垂直整合多州运营商，业务覆盖13个州，拥有15个生产设施，种植面积超过110万平方英尺[7] - 公司旗下拥有Zen Leaf和MÜV药房品牌，以及Verano、Essence、Savvy等多个产品品牌[7]

Alan Brochstein, CFA, is one of the first investment professionals to focus exclusively on the cannabis industry. Alan got his start as a financial professional in the securities industry in 1986, managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent consulting to registered investment advisors. He is also the managing partner of New Cannabis Ventures, a leading provider of relevant financial information in the cannabis industry si ...

股价表现 - 自7月初以来，公司股价大幅飙升约300% [1] - 过去五年间，公司股价仍下跌超过65% [3] 近期股价上涨催化剂 - 市场对美国大麻政策改革的预期，使投资者看好这家加拿大公司的增长潜力 [1] - 即将于10月9日发布的财报可能成为股价下一个催化剂 [2] 财务状况 - 在截至5月31日的最新财年，公司净收入为8.213亿美元，同比增长4% [5] - 核心大麻业务收入下降9%，该部门销售额降至2.49亿美元 [5] - 公司多年来持续亏损，盈利能力未见改善 [3][6] 业务运营与市场环境 - 加拿大大麻市场竞争异常激烈，导致公司及其他生产商业绩承压 [4] - 公司通过收购拓展至酒精和健康产品领域，实现收入多元化，降低了对大麻业务的依赖 [7] 财报后股价历史表现 - 公司季度财报发布后，股价通常不会出现积极上涨，反而常见抛售情况 [3] - 鉴于近期股价已大幅上涨，本月财报后可能再次面临大幅回调风险 [4]

Key Points Tilray rallied after President Trump posted a pro-CBD video on Truth Social last weekend. Tilray is also expanding its medical cannabis sales in Germany. However, investors would do well to not get their hopes up. 10 stocks we like better than Tilray Brands › Shares of cannabis company Tilray Brands (NASDAQ: TLRY) rallied some 40% this week through Thursday trading, according to data from S&P Global Market Intelligence. Last weekend, President Donald Trump posted a pro-cannabidiol (CB ...

Key Takeaways Trump's CBD video highlights the benefits for seniors, boosting cannabis legalization optimism.Village Farms expands globally with record export sales and consistent cannabis profitability.Canopy Growth trims costs and eyes U.S. growth while Tilray diversifies into beer and spirits.2025 is shaping up to be a breakthrough year for the cannabis industry. After years of sluggish growth and battered stock prices, the sector is finally gaining traction, largely driven by support from the Trump admi ...

TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that it has completed and filed its interim financial statements for the periods ended March 31, 2025 and June 30, 2025, and the related management's discussion and analysis and CEO and CFO certificates. Copies of the noted documents are available under the Company’s profile on SEDAR+ at www.sedarplus.ca. With the filing of these documents, the Company has now brought its continuous disclos ...

The stock remains significantly down from its all-time highs.Is this the year Tilray Brands (TLRY -2.42%) finally starts its comeback? During the past five years, the company has lagged broader equities as the cannabis industry, where it is a leader, continues to fall far short of expectations. However, Tilray Brands has been on fire this year, and during the past six months alone, the stock is up more than 150% (as of Oct. 2). Yet, the shares are still well into penny stock territory and are currently trad ...

文章核心观点 - 美国总统表态支持通过联邦医疗保险为老年人提供大麻二酚 引发多只大麻股股价显著上涨 [1][2] - 星座品牌作为 canopy growth 的主要股东 为投资者提供了间接参与大麻行业的多元化途径 [3][4] - 星座品牌股票在2025年表现疲软 当前估值偏高但提供可观股息收益率 [5][6] 大麻股市场反应 - 受特朗普总统在社交媒体上推广大麻二酚健康益处的视频影响 主要大麻股出现大幅上涨 其中 Tilray Brands 飙升42% Aurora Cannabis 上涨25% Canopy Growth 上涨18% Cronos Group 上涨15% [2] - 尽管部分股票在后续交易日回吐涨幅 但星座品牌股价对此消息反应平淡 [2] 星座品牌与大麻行业关联 - 星座品牌通过其壳公司 Greenstar Canada Investment Limited Partnership 持有约2600万股 Canopy Growth 股票 持股比例约为14% [3] - 这些股份为可交换股票 可按1比1比例转换为普通股 尽管星座品牌于2024年退出董事会并将普通股转换为无投票权和非参与性的可交换股票 但其仍为 Canopy Growth 的主要股东 [3] 星座品牌公司概况 - 星座品牌是美国第三大啤酒公司 同时生产高端葡萄酒和烈酒 旗下品牌包括科罗娜啤酒和金凯福葡萄酒 [4] - 公司市值为245亿美元 总部位于纽约州罗切斯特 [4][5] 星座品牌股票表现与估值 - 星座品牌股票在2025年表现不佳 年内下跌37% 较52周低点仅高出5% [5] - 其表现逊于竞争对手 波士顿啤酒公司2025年下跌26% 摩森康胜下跌20% [5] - 公司当前市盈率为46.4倍 高于其10年历史中位数25.8倍 估值偏高 [5] 星座品牌股息信息 - 公司提供3%的股息收益率 显著高于行业平均1.9%的收益率 [6] - 下一次股息支付日为2025年11月13日 股权登记日为2025年10月30日 [6]

Curaleaf Holdings, Inc. ( OTCPK:CURLF ) (TSX: CURA:CA ) reported in line financial results for Q2 2025 last August. The company announced that it will begin the expansion of international operations into Turkey. The EU recently announcedWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks ...